Evaluation of the Photosensitizer Tookad® for Photodynamic Therapy on the Syrian Golden Hamster Cheek Pouch Model: Light Dose, Drug Dose and Drug-light Interval Effects

Photochemistry and Photobiology

Volumn 78, Issue 4, 2003, Pages 377-383

  Borle, François ^a   Radu, Alexandre ^b   Monnier, Philippe ^b   Van den Bergh, Hubert ^a   Wagnières, Georges ^a  

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PALLADIUM; PALLADIUM BACTERIOPHEOPHORBIDE; PHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TEMOPORFIN; TOOKAD; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEEK POUCH; CONNECTIVE TISSUE; CONTROLLED STUDY; DECOMPOSITION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; EXPERIMENTAL MODEL; HAMSTER; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MEASUREMENT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARAMETER; PHOTODYNAMIC THERAPY; PREDICTION; RADIATION DOSE; RADIATION RESPONSE; SKELETAL MUSCLE; TISSUE REACTION;

ANIMALS; CHEEK; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG EVALUATION, PRECLINICAL; MALE; MESOCRICETUS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0242268560     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2003)078<0377:EOTPTF>2.0.CO;2     Document Type: Article

References (45)

1. Radu, A., G. Wagnières, H. van den Bergh and P. Monnier (2000) Photodynamic therapy of early squamous cell cancers of the esophagus. Gastrointest. Endosc. Clin. N. Am. 10(3), 439-460.
2. Metz J. M. and J. S. Friedberg (2001) Endobronchial photodynamic therapy for the treatment of lung cancer. Chest Surg. Clin. N. Am. 11(4), 829-839.
3. Savary, J. F., P. Monnier, C. Fontolliet, J. Mizeret, G. Wagnières, D. Braichotte and H. van den Bergh (1997) Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra(hydroxyphenyl)chlorin. Arch. Otolaryngol. Head Neck Surg. 123(2), 162-168.
4. Guillemin, F., I. Cosserat-Gerardin, D. Notter and C. Vigneron (2001) Diagnosis and treatment of bladder tumors by photodynamic therapy. Pathol. Biol. (Paris) 49(10), 815-823.
5. Jichlinski, P. and H.-J. Leisinger (2001) Photodynamic therapy in superficial bladder cancer: past, present and future. Urol. Res. 29, 396-405.
6. Brown, S. B. and K. J. Mellish (2001) Verteporfin: a milestone in ophthalmology and photodynamic therapy. Expert Opin. Pharmacother. 2(2), 351-361.
7. Fritsch, C., G. Goerz and T. Ruzicka (1998) Photodynamic therapy in dermatology. Arch. Dermatol. 134(2), 207-214.
8. Karrer, S., R. M. Szeimies, U. Hohenleutner and M. Landthaler (2001) Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am. J. Clin. Dermatol. 2(4), 229-237.
9. Webber, J., M. Herman, D. Kessel and D. Fromm (1999) Current concepts in gastrointestinal photodynamic therapy. Ann. Surg. 230(1), 12-23.
10. Grosjean, P., J. F. Savary, J. Mizeret, G. Wagnières, A. Woodtli, J. F. Theumann, C. Fontolliet, H. Van den Bergh and P. Monnier (1996) Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin. J. Clin. Laser Med. Surg. 14(5), 281-287.
11. Scherz, A., Y. Salomon, L. Fiedor and A. Brandis (2000) Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them. (Yeda Research and Development Co., Ltd., Israel). U.S., Patent. Application: US 98-33726 19980303.
12. Chen, Q., Z. Huang, D. Luck, J. Beckers, P.-H. Brun, B. C. Wilson, A. Scherz, Y. Salomon and F. W. Hetzel (2002) Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photochem. Photobiol. 76(4), 438-445.
13. Ritz, J. P., A. Roggan, C. Isbert, G. Muller, H. J. Buhr and C. T. Germer (2001) Optical properties of native and coagulated porcine liver tissue between 400 and 2400 nm. Lasers Surg. Med. 29(3), 205-212.
14. Rovers, J. P., M. L. de Jode and M. F. Grahn (2000) Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue. Lasers Surg. Med. 27(3), 235-240.
15. Scherz, A., Y. Salomon, A. Brandis and H. Scheer (2000) Steba Biotech investigation protocols (Yeda Research and Development Co., Ltd., Israel). Palladium-substituted bacteriochlorophyll derivatives and use thereof. Publication PCT Int. Appl. 59.
16. Rosenbach-Belkin, V., L. Chen, L. Fiedor, Y. Salomon and A. Scherz (1998) Chlorophyll and bacteriochlorophyll derivatives as photodynamic agents. In Photodynamic Tumor Therapy, (Edited by J.G. Moser and G. Joerg), pp. 117-125. Harwood, Amsterdam, The Netherlands.
17. Teuchner, K., H. Stiel, D. Leupold, A. Scherz, D. Noy, I. Simonin, G. Hartwich and H. Scheer (1997) Fluorescence and excited state absorption in modified pigments of bacterial photosynthesis a comparative study of metal-substituted bacteriochlorophylls a. J. Lumin. 72, 612-614.
18. Musewald, C., G. Hartwich, F. Poellinger-Dammer, H. Lossau, H. Scheer and M. E. Michel-Beyerle (1998) Time-resolved spectral investigation of bacteriochlorophyll a and its transmetalated derivatives [Zn]-bacteriochlorophyll a and [Pd]-bacteriochlorophyll a. J. Phys. Chem. B 102(42), 8336-8342.
19. Weersink, R. A., B. C. Wilson, K. Adams and M. S. Patterson (2002) Determination of pharmacokinetics of Tookad® in vivo using dynamic, spatially resolved diffuse reflectance spectroscopy in a rabbit model. SPIE Conf. Bios Biomed. Opt. 4613, 135-142.
20. Koudinova, N. V., J. H. Pinthus, A. Brandis, O. Brenner, P. Bendel, J. Ramon, Z. Eshhar, A. Scherz and Y. Salomon (2003) Photodynamic therapy with Pd-bacteriopheophorbide (Tookad): successful in vivo treatment of human prostafic small cell carcinoma xenografts. Int. J. Cancer 104(6), 782-789.
21. Andrejevic Blant, S., P. Grosjean, J. P. Ballini, G. Wagnières, H. van den Bergh, C. Fontolliet and P. Monnier (2001) Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study. J. Photochem. Photobiol. B: Biol. 61(1-2), 1-9.
22. Andrejevic-Blant, S., C. Hadjur, J. P. Ballini, G. Wagnières, C. Fontolliet, H. van den Bergh and P. Monnier (1997) Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. Br. J. Cancer 76(8), 1021-1028.
23. Kingsbury, J. S., W. Cecere, T. S. Mang and C. Liebow (1997) Photodynamic therapy for premalignant lesions in DMBA-treated hamsters: a preliminary study. J. Oral Maxillofac. Surg. 55(4), 376-381.
24. Andrejevic Blant, S., J. P. Ballini, H. van den Bergh, C. Fontolliet, G. Wagnières and P. Monnier (2000) Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study. Photochem. Photobiol. 71(3), 333-340.
25. Blant, S. A., A. Woodtli, G. Wagnières, C. Fontolliet, H. van den Bergh and P. Monnier (1996) In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin. Photochem. Photobiol. 64(6), 963-968.
26. Andrejevic Blant, S., J.-F. Theumann, M. Forrer, G. Wagnières, H. van den Bergh and P. Monnier (1997) Wavelength-dependent effect of tetra(m-hydroxyphenyl)chlorin for photodynamic therapy in an "early" squamous cell carcinoma model. Laser Med. Sci. 12, 269-273.
27. Zellweger, M., A. Radu, P. Monnier, H. van den Bergh and G. Wagnières (2000) Fluorescence pharmacokinetics of Lutetium Texaphyrin (PCI-0123, Lu-Tex) in the skin and in healthy and tumoral hamster cheek-pouch mucosa. J. Photochem. Photobiol. B: Biol. 55(1), 56-62.
28. Andrejevic-Blant, S., A. Woodtli, G. Wagnieres, C. Fontolliet, H. van den Bergh and P. Monnier (1998) Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: tumor versus striated muscle damage. Int. J. Radiat. Oncol. Biol. Phys. 42(2), 403-412.
29. Hartwich, G., L. Fiedor, I. Simonin, E. Cmiel, W. Schafer, D. Noy, A. Scherz and H. Scheer (1998) Metal-substituted bacteriochlorophylls. Preparation and influence of metal and coordination on spectra. J. Am. Chem. Soc. 120(15), 3675-3683.
30. Glanzmann, T., M. Forrer, S. A. Blant, A. Woodtli, P. Grosjean, D. Braichotte, H. van den Bergh, P. Monnier and G. Wagnières (2000) Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)-chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements. J. Photochem. Photobiol. B: Biol. 57(1), 22-32.
31. Brown, S. B., D. I. Vernon, J. A. Holroyd, S. Marcus, R. Trust, W. Hawkins, A. Shah and A. Tonelli Pharmacokinetics of photofrin in man. In Photodynamic Therapy and Biomedical Laser (Edited by P. Spinelli, M. Dalfante and R. Marchesini), pp. 475-479. Elsevier Science, Amsterdam, The Netherlands. 1992
32. Richter, A. M., E. Waterfield, A. K. Jain, B. Allison, E. D. Sternberg, D. Dolphin and J. G. Levy (1991) Photosensitizing potency of structural analogs of benzoporphyrin derivative (BPD) in a mouse tumor model. Br. J. Cancer 63, 93-97.
33. Marijnissen, J. P., J. A. Versteeg, W. M. Star and W. L. van Putten (1992) Tumor and normal tissue response to interstitial photodynamic therapy of the rat R-1 rhabdomyosarcoma. Int. J. Radiat. Oncol. Biol. Phys. 22(5), 963-972.
34. Farrell, T. J., B. C. Wilson, M. S. Patterson and M. C. Olivo (1998) Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model. Photochem. Photobiol. 68(3), 394-399.
35. Post, J. G., J. A. te Poele, J. J. Schuitmaker and F. A. Stewart (1996) A comparison of functional bladder damage after intravesical photodynamic therapy with three different photosensitizers. Photochem Photobiol. 63(3), 314-321.
36. Renno, R. Z. and J. W. Miller (2001) Photosensitizer delivery for photodynamic therapy of choroidal neovascularization. Adv. Drug Delivery Rev. 52(1), 63-78.
37. Rockson, S. G., D. P. Lorenz, W. F. Cheong and K. W. Woodbum (2000) Photoangioplasty: an emerging clinical cardiovascular role for photodynamic therapy. Circulation 102(5), 591-596.
38. Trauner, K. B., R. Gandour-Edwards, M. Bamberg, S. Shortkroff, C. Sledge and T. Hasan (1998) Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem. Photobiol. 67(1), 133-139.
39. Los, M. and E. E. Voest (2001) The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer. Semin. Oncol. 28(1), 93-105.
40. Yamaguchi, A., K. W. Woodburn, M. Hayase, G. Hoyt and R. C. Robbins (2001) Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease. Transplantation 71(11), 1526-1532.
41. Chowdhary, R. K., L. G. Ratkay, A. J. Canaan, J. D. Waterfield, A. M. Richter and J. G. Levy (1998) Uptake of verteporfin by articular tissues following systemic and intra-articular administration. Biopharm. Drug Dispos. 19(6), 395-400.
42. Veenhuizen, R. B., M. C. Ruevekamp, H. Oppelaar, B. Ransdorp, M. van de Vijver, T. J. Helmerhorst, P. Kenemans and F. A. Stewart (1997) Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxicity. Photochem. Photobiol. 66(3), 389-395.
43. Grosjean, P., G. Wagnières, C. Fontolliet, H. van den Bergh and P. Monnier (1998) Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br. J. Cancer 77(11), 1989-1995.
44. Nseyo, U. O., D. C. Merrill and S. L. Lundahl (1993) Green light photodynamic therapy in the human bladder. Clin. Laser Mon. 11(5), 247-250.
45. Zilberstein, J., S. Schreiber, M. Bloemers, P. Bendel, M. Neeman, E. Schechtman, F. Kohen, A. Scherz and Y. Salomon (2001) Antivascular treatment of solid melanoma tumors with bacteriochlorophyll-serine based photodynamic therapy. Photochem. Photobiol. 73, 257-266.